Search

Your search keyword '"Joseph J. Skitzki"' showing total 124 results

Search Constraints

Start Over You searched for: Author "Joseph J. Skitzki" Remove constraint Author: "Joseph J. Skitzki"
124 results on '"Joseph J. Skitzki"'

Search Results

101. Melanoma trials that defined surgical management: Brief overview of current/upcoming adjuvant/neoadjuvant trials.

102. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.

103. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee.

104. NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019.

105. Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

106. Intra-arterial Versus Intravenous Adoptive Cell Therapy in a Mouse Tumor Model.

107. Malignant adnexal tumors of the skin: a single institution experience.

108. Conditional Survival-Based "Abbreviated" Routine Cancer Surveillance for Pathologic Stage IB Melanoma.

109. Water lavage as an adjunct to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).

111. Key gaps in pathologic reporting for appendiceal mucinous neoplasms: time for universal synoptic reporting?

112. Technical Considerations for the Generation of Adoptively Transferred T Cells in Cancer Immunotherapy.

113. NCCN Guidelines Insights: Melanoma, Version 3.2016.

114. Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

115. Current Immunotherapies for Sarcoma: Clinical Trials and Rationale.

116. Incidence of Venous Thromboembolic Events in Mandated Risk Assessment versus Optional DVT Prophylaxis Era at a Large Tertiary Cancer Center.

117. The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options.

118. Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents.

119. Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.

120. Primary signet-ring cell carcinoma of the axilla.

121. Academic university practice: program selection and the interview process.

122. Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy.

123. Donor cell cycling, trafficking, and accumulation during adoptive immunotherapy for murine lung metastases.

124. Intratumoral IL-12 and TNF-alpha-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity.

Catalog

Books, media, physical & digital resources